Tirzepatide is the primary topic on Retapedia for the
terms listed below. This page distinguishes other meanings and
related entries.
Tirzepatide (also called Tirzepatide, GIP/GLP-1 dual agonist, Mounjaro, Zepbound) may refer to:
Primary topic
- Tirzepatide — Dual GIP/GLP-1 agonist. Reduces appetite for up to 21% weight loss. Improves blood sugar and diabetes control. First drug approved for obstructive sleep apnea. GI side effects common.
Also known as
The following names are catalogued aliases for the primary topic:
- Tirzepatide
- GIP/GLP-1 dual agonist
- Mounjaro
- Zepbound
External meanings
The term Tirzepatide may carry meanings outside this catalogue — for example, as a developmental code shared with an unrelated chemical entity, or as a trademarked product name in a different therapeutic area. Retapedia does not catalogue non-peptide compounds; consult an external reference such as PubChem or Wikidata for broader coverage.
Categories:
Disambiguation pages